Loading…
Leukocyte-derived koebnerisin (S100A15) and psoriasin (S100A7) are systemic mediators of inflammation in psoriasis
Highlights • Leukocytes are a novel source of koebnerisin (S100A15) and psoriasin (S100A7). • Koebnerisin and psoriasin are induced in leukocytes of patients with psoriasis. • Koebnerisin but not psoriasin regulation marks PASI improvement by UVB therapy. • Koebnerisin and psoriasin act as ‘alarmins...
Saved in:
Published in: | Journal of dermatological science 2015-09, Vol.79 (3), p.214-221 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Highlights • Leukocytes are a novel source of koebnerisin (S100A15) and psoriasin (S100A7). • Koebnerisin and psoriasin are induced in leukocytes of patients with psoriasis. • Koebnerisin but not psoriasin regulation marks PASI improvement by UVB therapy. • Koebnerisin and psoriasin act as ‘alarmins’ on leukocytes to produce proinflammatory cytokines. • Koebnerisin and psoriasin are multifunctional mediators of inflammation. |
---|---|
ISSN: | 0923-1811 1873-569X |
DOI: | 10.1016/j.jdermsci.2015.05.007 |